LINC00654 confers sorafenib resistance by suppressing ferroptosis via STAT3-mediated transcriptional activation of SLC7A11 in hepatocellular carcinoma-Reference-Cited by-同舟云学术

LINC00654 confers sorafenib resistance by suppressing ferroptosis via STAT3-mediated transcriptional activation of SLC7A11 in hepatocellular carcinoma

Published:2023-07 Issue: Volume:669 Page:131458
ISSN:0927-7757
Container-title:Colloids and Surfaces A: Physicochemical and Engineering Aspects
language:en
Short-container-title:Colloids and Surfaces A: Physicochemical and Engineering Aspects

Author:

Peng Huanyan,Xu An,Sun Chao,Tong Fang,Kang Xiaofeng,Zhou Huifang,Kang Jiwen,Li Xingyu,Han Yuchen,Xue Chunyuan,Tang Chuanhao,Fang Liaoxin,Du Yimeng,Han Juqiang,Sun Dianxing

Funder

Natural Science Foundation of Beijing Municipality

Hebei Province Medical Science Research Key Project

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry

Reference54 articles.

1. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities;Golabi;Medicine,2017

2. Hepatocellular carcinoma;Vogel;Lancet,2022

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

4. Ferroptosis: an iron-dependent form of nonapoptotic cell death;Dixon;Cell,2012

5. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer;Nakamura;J. Biol. Chem.,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of sorafenib resistance in hepatocellular carcinoma;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Novel Therapeutic Approach for Psoriasis: Upregulating FcRn to Inhibit Ferroptosis and Alleviate Lesional skin;Free Radical Biology and Medicine;2024-09